Piper Sandler Raises UnitedHealth (UNH) Price Target to $504

Piper Sandler has reiterated its Overweight rating on UnitedHealth Group Incorporated (NYSE: UNH) on October 14, 2026, with a new price target of $504, up from the previous target of $502. This reflects the firm's ongoing confidence in the company despite current market valuations.

Piper Sandler's Call on UnitedHealth Group

Piper Sandler maintains an Overweight rating for UnitedHealth, indicating a positive outlook. The firm set a price target of $504, an increase from the previous target of $502. This suggests that Piper Sandler sees potential for growth in UnitedHealth shares.

Other Institutional Activity in UnitedHealth Group

In addition to Piper Sandler, several other institutional investors are holding significant stakes in UnitedHealth. Blackrock Inc. holds 76,863,061 shares valued at about $30.9 billion, having increased its position by 3,394,259 shares. Vanguard Capital Management LLC owns 59,311,525 shares worth approximately $23.8 billion, with a slight increase of 441,525 shares. State Street Corporation has 45,633,267 shares valued at about $18.3 billion, increasing its stake by 299,205 shares. Capital World Investors holds 29,887,932 shares worth around $12.0 billion, having boosted its holdings by 2,103,297 shares. FMR, LLC has 27,992,995 shares valued at about $11.2 billion, with a significant increase of 15,974,192 shares.

UnitedHealth Group Incorporated Stock Up 1.7%

UnitedHealth shares are recently trading at $402.35, which is above the 50-day moving average of $387.35 and the 200-day moving average of $358.75, indicating a strong performance relative to these benchmarks. However, the stock is about 12.8% below its 52-week high of $461.62 and 20.2% below the average analyst target of $477.04.

Recent Earnings

In its latest earnings report, UnitedHealth reported trailing twelve-month revenue of approximately $450.1 billion and an EPS of $15.55. The company has a net margin of 3.5% and return on equity of 15.8%. The next earnings report is scheduled for January 26, 2027.

Insider Buying and Selling at UnitedHealth Group Incorporated

Several insider transactions have been reported recently. Patrick Hugh Conway, an officer, sold 1,169 shares at an average price of $390 on August 21, 2026, totaling about $455,910. Earlier, he also sold 500 shares at $410 on August 5, 2026, for a value of $205,000. These transactions occurred before the current rating by Piper Sandler.

Analysts Set New Price Targets

On October 14, 2026, Piper Sandler reiterated its Overweight rating with a price target of $504. Barclays also maintained an Overweight rating with a target of $440, while Baird kept a Neutral rating with a target of $427.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health care company that operates through segments like Optum and UnitedHealthcare. It provides a range of health services, including care delivery and management, wellness programs, and health financial services. The company's robust market position and broad service offerings are key factors in its ongoing performance and investor interest.

Bottom Line

Investors will be watching UnitedHealth as it approaches its next earnings date on January 26, 2027. Piper Sandler's recent target reiteration highlights the firm's confidence in the company's future, despite the stock trading below its target price. Further analyst ratings and institutional movements will provide additional insights into market sentiment.